| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.8 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | -0.047 | 0.8 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |